The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence

Journal of Internal Medicine
G Walldius, I Jungner

Abstract

During the last several years interest has focused on the importance of the lipid-transporting apolipoproteins--apoB transports all potentially atherogenic very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL) and LDL particles, and apoA-I transports and acts as the major antiatherogenic protein in the HDL particles. The evidence for the apoB/apoA-I ratio being a strong, new risk factor for cardiovascular (CV) disease and a target for lipid-lowering therapy is reviewed. Results from clinical prospective studies and lipid-lowering trials in healthy subjects and in patients with different clinical manifestations of atherosclerosis are reported. Risk of nonfatal and fatal myocardial infarction and stroke, and manifestations of atherosclerosis documented by angiographic, ultrasound and other techniques has been related to conventional lipids and apolipoproteins (apo). The cholesterol balance determined as the apoB/apoA-I ratio has repeatedly been shown to be a better marker than lipids, lipoproteins and lipid ratios. The results indicate that the apoB/apoA-I ratio is a simple, accurate and new risk factor for CV disease--the lower the apoB/apoA-I ratio, the lower is the risk. Guidelines should be developed in ...Continue Reading

References

Jan 1, 1992·International Journal of Clinical & Laboratory Research·I JungnerE Steiner
Sep 18, 1986·The New England Journal of Medicine·D S FreedmanG S Berenson
Nov 1, 1994·Annals of Internal Medicine·B KinosianG Garland
Jul 22, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·H T WesterveldD W Erkelens
May 20, 1999·Circulation·A J MossR B Case
Jun 22, 1999·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·I S OkosunR S Cooper
Apr 18, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·J H ContoisC J Lammi-Keefe
Nov 14, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·J E van LennepE E van der Wall
Dec 15, 2000·European Journal of Clinical Investigation·P M SweetnamJ W Yarnell
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jul 4, 2001·Clinical Chemistry and Laboratory Medicine : CCLM·H ScharnaglW März
Jul 27, 2001·The American Journal of Cardiology·C M BallantyneUNKNOWN ACCESS Study Group. Atorvastatin Comparative Cholesterol Efficacy and Safety Study
Jan 5, 2002·Diabetes/metabolism Research and Reviews·C SnehalathaA Ramachandran
Jan 30, 2002·Journal of Epidemiology and Community Health·M L BotsD E Grobbee
Feb 9, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Eric T P KeulenTjerk W A de Bruin
Nov 7, 2002·The American Journal of Cardiology·James D OtvosWilliam C Cromwell
Nov 12, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Philippa J TalmudSteve E Humphries
Dec 11, 2002·European Heart Journal·P Di NapoliR De Caterina
May 15, 2003·The American Journal of Cardiology·Allan D SnidermanBenoît Lamarche
Jul 16, 2003·Archives of Internal Medicine·Annelies W E Weverling-RijnsburgerRudi G J Westendorp
Aug 2, 2003·American Heart Journal·Christie M Ballantyne, Ron C Hoogeveen

❮ Previous
Next ❯

Citations

Jan 16, 2007·Journal of Physiology and Biochemistry·G BuenoM Bueno
Nov 15, 2006·Analytical and Bioanalytical Chemistry·Kan-Zhi LiuR Anthony Shaw
Apr 28, 2011·Clinical Rheumatology·Saoussen Hassen ZrourNaceur Bergaoui
May 13, 2011·Cancer Causes & Control : CCC·Mieke Van HemelrijckLars Holmberg
Aug 12, 2006·Current Atherosclerosis Reports·Natalie Khuseyinova, Wolfgang Koenig
Jan 5, 2008·Current Atherosclerosis Reports·Allan D Sniderman, Robert S Kiss
Jul 21, 2011·Current Atherosclerosis Reports·Sandeep S Mangalmurti, Michael H Davidson
Jan 25, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiao-Bing JiangHai-Jun Wang
Jun 27, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Axel C CarlssonMai-Lis Hellénius
Nov 7, 2007·Nature Clinical Practice. Cardiovascular Medicine·Justo Sierra-Johnson, Rachel M Fisher
Apr 5, 2012·Metabolic Syndrome and Related Disorders·Alireza EsteghamatiManouchehr Nakhjavani
May 23, 2008·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Ma Luisa OjedaOlimpia Carreras
Jun 13, 2009·European Heart Journal·Sarah ParishUNKNOWN International Studies of Infarct Survival Collaborators
Apr 3, 2008·Clinical Neuropharmacology·Rodrigo Daniel SantamarinaSergio Eduardo Gonorazky
Sep 1, 2011·Therapeutic Advances in Chronic Disease·Michel P Hermans, Jean-Charles Fruchart
Dec 24, 2009·BMC Cardiovascular Disorders·Hannah GardenerTatjana Rundek
Jun 12, 2012·Nutrition & Metabolism·Natalia PetrenyaJon Oyvind Odland
Sep 24, 2009·Vascular Health and Risk Management·Jesús MillánJuan Pedro-Botet
Apr 22, 2014·Vascular Health and Risk Management·Bishnu H SubediErin D Michos
May 8, 2008·Journal of the American College of Nutrition·Maria Luz Fernandez, Densie Webb
Oct 7, 2010·Indian Journal of Pediatrics·S Savas ErdeveZeynep Biyikli
Feb 26, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Yuji SatoShuji Iwatsubo

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.